Drug Pipeline

Gemtuzumab Ozogamicin Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
11
Active Studies
9
Recruiting
2
Phase 3
6
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT06917911
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment…		 Trial sites expanded: 7 -> 14 locations
2026-05-23 NCT06917911
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment…		 Recruitment opened
2026-05-23 NCT06917911
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment…		 Trial sites expanded: 0 -> 6 locations
Active Studies by Phase
Phase 3
2
Phase 2
8
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04293562 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for… Acute Myeloid Leukemia Recruiting
NCT05183035 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia Recruiting
Phase 2
NCT03737955 Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients… Acute Myeloid Leukemia Recruiting
NCT00801489 Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin… Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Recruiting
NCT01409161 Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients… Acute Promyelocytic Leukemia With PML-RARA Recruiting
NCT03589729 Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in… Acute Myeloid Leukemia Recruiting
NCT05564390 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… Acute Myeloid Leukemia Recruiting
NCT06917911 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment… Core Binding Factor Acute Myeloid Leukemia Recruiting
NCT03672539 Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating… Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Active, Not Recruiting
NCT00658814 Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously… Acute Myeloid Leukemia Active, Not Recruiting
Phase 1
NCT05558124 CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML Acute Myeloid Leukemia Recruiting
Sponsors Running Gemtuzumab Ozogamicin Trials
M.D. Anderson Cancer Center (4) National Cancer Institute (NCI) (3) University of Washington (1) Children's Oncology Group (1) PedAL BCU, LLC (1) H. Lee Moffitt Cancer Center and Research Institute (1)
Disease Areas
Leukemia (11) Acute Myeloid Leukemia (AML) (10) Myelodysplastic Syndromes (MDS) (4) Myelofibrosis (2) Sarcoma (1)
Get alerts when Gemtuzumab Ozogamicin trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free